摘要
目的评价米非司酮联合甲氨蝶呤保守治疗宫外孕临床现状。方法选择2014年3月~2015年3月在辽宁省凤城市妇幼保健院接受诊治的60例宫外孕病患,均分成两组。对照组选择甲氨蝶呤,实验组以米非司酮联合甲氨蝶呤保守治疗为主。结果两组病患临床效果差异有统计学意义(P〈0.05)。结论以米非司酮联合甲氨蝶呤保守治疗为主要方案治疗宫外孕病患能够提升其临床效果。
Objective To evaluate the clinical status of mifepristone combined with methotrexate in treatment of ectopic pregnancy.Methods 60 cases of ectopic pregnancy disease patients were divided into two groups 2014 March 2015 March in Fengcheng City,Liaoning Province Maternal and child health care hospital.The control group experimental group with methotrexate,mifepristone combined with methotrexate therapy.Results Two groups of patients with clinical effect is obvious difference(P〈0.05).Conclusion Mifepristone combined with methotrexate in conservative treatment as the main scheme treatment ectopic pregnancy disease patients can improve the clinical effect.
出处
《中国继续医学教育》
2015年第17期157-158,共2页
China Continuing Medical Education
关键词
米非司酮
甲氨蝶呤
保守治疗
宫外孕
临床观察
Mifepristone
Methotrexate
Conservative treatment
Ectopic pregnancy
Clinical observation